Growth hormone releasing peptides: Growth studies

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 2, 1999, Pages 100-105

  Bach, Mark A ^a   Cambria, Marnie ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE; CAPROMORELIN; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; HUMAN GROWTH HORMONE; IBUTAMOREN; IPAMORELIN; PRALMORELIN; SERMORELIN; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HEIGHT; HORMONAL THERAPY; HORMONE RELEASE; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACODYNAMICS; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0033042711     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199904000-00003     Document Type: Article

References (36)

1. 1 Bowers CY, Chang J, Momany F, Folkers K: Effect of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. In: McIntyre I, ed. Molecular endocrinology. Amsterdam: Elsevier/North Holland; 1977:287.
2. 2 Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al.: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
3. 3 Bowers CY, Reynolds GA, Chang D, Hong A, Chang K, Momany F: A study on the regulation of growth hormone release from the pituitaries of rats in vitro. Endocrinology 1981, 108:1071-1080.
4. 4 Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DB, et al.: Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 1995, 92:7001-7005.
5. 5 Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, et al.: Growth-hormone response in man to I-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 1993, 77:1393-1397.
6. 6 Carpino PA, Lefker BA, Toler SM, Pan LC, Cook ER, DiBrino JN, et al.: Discovery of the novel pyrazolidinone-piperidine growth hormone secretagogue CP-424,391 [Abstract]. Endocrine Society Meeting, New Orleans, LA, 1998:P2-190.
7. 7 Rasmussen MH, Sogaard B, Ynddal L, Groes L, Helmgaard L, Nordholm L: Ipamorelin-a very potent novel growth hormone secretagogue [Abstract]. Endocrine Society Meeting, New Orleans, LA 1998P1-185.
8. 8 Guillaume V, Magnan E, Cataldi M. Dutour A, Sauze N, Renard M, et al.: Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 1994, 135:1073-1076.
9. 9 Pombo M, Casanueva FF, Dieguez C, Peino R, Penalva A, Barreiro J: Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab 1995, 80:3180-4.
10. 10 Popovic V, Damjanovic S, Micic D, Djurovic M, Doknic M, Dieguez C, et al.: Growth hormone secretion after ghrh and ghrp-6 in patients with hypothalamo-pituitary disconnection [Abstract]. J Endocrinol 1995, 144:P96.
11. 11 Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR: Growth hormone (gh) responses to gh-releasing peptide and to gh-releasing hormone in gh-deficient children. J Clin Endocrinol Metab 1995, 80:1681-1684.
12. 12 Pihoker C, Bowers CY, French D, Kearns GL: Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. J Clin Endocrinol Metab 1998, 83:1168-72.
13. 13 Tiulpakov AN, Bulatov AA, Peterkova VA, Elizarova GP, Volevodz NN, Bowers CY: Growth-hormone (gh)-releasing effects of synthetic peptide gh-releasing peptide-2 and gh-releasing hormone(1-29nh(2)) in children with gh insufficiency and idiopathic short stature. Metab Clin Exp 1995, 44:1199-1204.
14. 14 Loche S, Cambiaso P, Merola B, Colao A, Faedda A, Imbimbo BP, et al.: The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J Clin Endocrinol Metab 1995, 80:2692-2696.
15. 15 Pombo M, Leal-Cerro A, Barreiro J, Penalva A, Peino R, Mallo F, et al.: Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency. J Pediatr Endocrinol Metab 1996, 9:333-338.
16. 16 Bercu BB, Walker RF: Growth hormone secretagogues in children with altered growth. Acta Paediatr Suppl 1997, 423:102-106.
17. 17 Yu H, Cassorla F, Tiulpakov AN, Shi Y, Setian N, Bercu B, et al.: Growth hormone response to single doses of MK-0677, an oral GH secretagogue, in growth hormone deficient children. Growth hormone and IGF-I research 1998, 8:332-333.
18. 18 Wyatt DT, Mark D, Slyper A: Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995, 80:3292-3297.
19. 19 Kemp SF: Growth hormone therapeutic practice: dosing issues. Endocrinologist 1996, 6:231-237.
20. 20 Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, et al. and The French Serono Study Group: A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J Clin Endocrinol Metab 1997, 82:452-456.
21. 21 MacGillivray MH, Baptista J, Johanson A, The Genentech Study Group: Outcome of a four year randomized study of daily vs. three times weekly somatotropin treatment in prepubertal naive GH deficient children. J Clin Endocrinol Metab 1996, 81:1806.
22. 22 Blethen SL, Baptista J, Kuntze J, Foley T, Lafranchi S, Johanson A, The Genentech Growth Study Group: Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab 1997, 82:418-420.
23. 23 Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A: Factors predicting the response to growth-hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endrocrinol Metab 1993, 76:574-579.
24. 24 Barton JS, Gardineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA: The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol (Oxf) 1995, 42:619-626.
25. 25 Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, et al.: Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993, 123:215-222.
26. 26 Ranke MB, Lindberg A: Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 1994, 406:18-23.
27. 27 Wit JM, Boersma B, de Muinck Keizer Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, et al: Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) 1995, 42:365-372.
28. 28 Thorner MO, Rogol AD, Blizzard RM, Klingensmith GJ, Najjar J, Misra R, et al.: Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone. Pediatr Res 1988, 24:145-151.
29. 29 Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. and the Geref International Study Group: Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab 1996, 81:1189-1196.
30. 30 Smith PJ, Brook CGD: Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency? Arch Dis Child 1988, 63:629-634.
31. 2 in children with idiopathic short stature induces a sustained increase in growth velocity. Clin Endocrinol 1994, 41:487-493.
32. 32 Laron Z, Frenkel J, Deghenghi R, Anin S, Klinger B, Silbergeld A: Intranasal administration of the ghrp hexarelin accelerates growth in short children. Clin Endocrinol 1995, 43:631-635.
33. 33 Pihoker C, Bowers CY, Reynolds GA, Badger TM: Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J Endocrinol 1997, 155:79-86.
34. 34 Mericq V, Merriam GR, Bowers CY, Iniguez G, Avila A, Salazar T, et al.: Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J Clin Endocrinol Metab 1998, 83:2355-60.
35. 35 Yu H, Cassorla F, Tiulpakov A, Shi Y, Setian N, Bercu B, et al.: A double-blind placebo-controlled efficacy trial of oral MK-0677 in growth hormone deficient (GHD) children [Abstract]. ENDO98, New Orleans, LA, 1998.
36. 36 Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa D, Taylor AM, et al.: Stimulation of the growth hormone (GH)/IGF-I axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects. J Clin Endocrinol Metab 1996, 81:4249-4257.